COVID-19

Sales & Marketing

Sustained healthcare systems need sustainable pharma busines...

COVID-19 demonstrated the importance of robust supply chains and the dangers of an over reliance on overseas manufacturing.

News

FDA okays Moderna, J&J COVID jab boosters, plus ‘mix and mat...

The FDA has authorised booster shots with Moderna and Johnson & Johnson’s COVID-19 vaccines, a month after giving the go-ahead to a third-dose of Pfizer/BioNTech’s shot.

News

Delta variant keeps Roche diagnostics sales sky high

High demand for COVID-19 diagnostics driven by the delta variant has led to rocketing sales at Roche's diagnostics division, allowing the company to raise its sales forecast for the year.

News

J&J mulls switch from non-profit status for COVID jab

Johnson & Johnson has been offering its COVID-19 vaccine for sale on a no-profit basis since it became available, but is thinking about a possible switch to a standard commercial model

Views & Analysis

Make locally led public health ‘business as usual’, says rep...

COVID-19 proved the value of locally led, place-based public health – but teams need long-term funding and support if they are to take their place as an essential cog in the ICS machine.

Views & Analysis

Blue neon path across endless labyrinth. Success, perspective vision, business strategy and marketing concept: Abstract 3D illustration

COVID-19 has propelled the regulatory industry years ahead

Janssen’s Saskia De Haes, VP EMEA Regulatory Affairs, looks at how the pandemic response has shaped tomorrow’s regulatory landscape.

Sustained healthcare systems need sustainable pharma busines...

FDA okays Moderna, J&J COVID jab boosters, plus ‘mix and mat...

Delta variant keeps Roche diagnostics sales sky high

J&J mulls switch from non-profit status for COVID jab

Make locally led public health ‘business as usual’, says rep...

COVID-19 has propelled the regulatory industry years ahead

Recordati gets €10.9bn takeover bid from private equity firm

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks